Calamos Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$58.5M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$31.2M |
| 3 |
Apple
AAPL
|
+$24.7M |
| 4 |
NCR Voyix
VYX
|
+$23.5M |
| 5 |
Amgen
AMGN
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$55.5M |
| 2 |
AMT.PRA
American Tower Corporation
AMT.PRA
|
+$53.6M |
| 3 |
Meta Platforms (Facebook)
META
|
+$48.2M |
| 4 |
EXCU
Exelon Corporation
EXCU
|
+$46.4M |
| 5 |
Costco
COST
|
+$37.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11% |
| 2 | Technology | 9.33% |
| 3 | Healthcare | 8.36% |
| 4 | Industrials | 6.68% |
| 5 | Communication Services | 6.6% |
Similar funds
Calamos Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Calamos Advisors held 671 positions worth $13.5B, up 6.5% from $12.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Calamos Advisors withdrew a net $2.52B in Q2 2017, closing 65 positions and reducing 141 holdings. Its most notable exit was American Tower Corporation, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 worth $59.5M.
- Calamos Advisors's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 1,086,994 shares worth $59.5M.
- Calamos Advisors added most to Alexion Pharmaceuticals in Q2 2017, an estimated $31.2M increase.
- Calamos Advisors's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $55.5M.
- Calamos Advisors fully exited American Tower Corporation in Q2 2017, selling an estimated $53.6M.
- Calamos Advisors's ten largest holdings make up 17% of its $13.5B portfolio in Q2 2017.
- Calamos Advisors opened 60 new positions and closed 65 in Q2 2017.
- Calamos Advisors's portfolio value rose 6.5% quarter-over-quarter to $13.5B.
Based on Calamos Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.